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A suite of models was developed to study the role of inositol 1,4,5-trisphosphate
receptor 1 (IP3R1) in spinocerebellar ataxias (SCAs). Several SCAs are linked to reduced
abundance of IP3R1 or to supranormal sensitivity of the receptor to activation by its ligand
inositol 1,4,5-trisphosphate (IP3). Detailed multidimensional models have been created
to simulate biochemical calcium signaling and membrane electrophysiology in cerebellar
Purkinje neurons. In these models, IP3R1-mediated calcium release is allowed to interact
with ion channel response on the cell membrane. Experimental findings in mice and
clinical observations in humans provide data input for the models. The SCA modeling suite
helps interpret experimental results and provides suggestions to guide experiments. The
models predict IP3R1 supersensitivity in SCA1 and compensatory mechanisms in SCA1,
SCA2, and SCA3. Simulations explain the impact of calcium buffer proteins. Results show
that IP3R1-mediated calcium release activates voltage-gated calcium-activated potassium
channels in the plasma membrane. The SCA modeling suite unifies observations from
experiments in a number of SCAs. The cadre of simulations demonstrates the central role
of IP3R1.
Keywords: spinocerebellar ataxia, translational, model, computational, inositol 1,4,5-trisphosphate receptor 1,
Purkinje, carbonic anhydrase related proteins, homer
INTRODUCTION
Several classes of spinocerebellar ataxia in humans and mice are
associated with reduced IP3R1 levels (Matsumoto et al., 1996;
Street et al., 1997; Zecevic et al., 1999; Lin et al., 2000; Ogura et al.,
2001; Serra et al., 2004; Kurnellas et al., 2007; van de Leemput
et al., 2007; Chou et al., 2008; Novak et al., 2010b; Castrioto et al.,
2011; Marelli et al., 2011; Huang et al., 2012; Obayashi et al.,
2012; Hansen et al., 2013; Sugawara et al., 2013) or increased
sensitivity of the receptor to IP3 (Inoue et al., 2001; Chen et al.,
2008; Liu et al., 2009), or both. Such disorders may be termed
“IP3R1-associated ataxias” (Brown and Loew, 2009, 2012), which
also encompasses ataxias with yet undetermined IP3R1 charac-
teristics (e.g., Huang et al., 2012; Conroy et al., 2014). Beyond
IP3R1-associated ataxias, a vast majority of ataxias converge on
IP3R1-dependent signaling (Figure 1). Schorge et al. argue that
the unifying feature of many cerebellar ataxias is their impact on
IP3R1 (Schorge et al., 2010).
The SCA modeling suite is a collection of well-mixed (com-
partmental) and spatial (1D, 3D) computational models that
simulate the biochemical and electrophysiological properties of
the cerebellar Purkinje neuron involving various calcium signal-
ing and ion channel molecules in constructed or experimentally
derived geometries (Supplemental Material, Supplemental Figure
S1 and Supplemental Table S1). The SCA suite examines the role
of IP3R1 in SCA pathophysiology (Brown and Loew, 2012), with
potential for translational studies.
NOVEL PREDICTIONS FROM THE SCA MODELING SUITE
COINCIDENCE DETECTION TIME WINDOW AT SPINE IP3R1
Cerebellar Purkinje neurons receive input from more than
150,000 granule cell axons (parallel fibers), leading to hydroly-
sis of PIP2 and subsequent IP3-mediated calcium release from
the endoplasmic reticulum (ER) (Finch and Augustine, 1998;
Takechi et al., 1998; Berridge et al., 2000; Cohen, 2003) (Figure 1).
Models 1–7 explored PIP2 signaling and IP3 production (Xu
et al., 2003; Hernjak et al., 2005; Brown et al., 2008). Results
from Models 4–7 indicated that baseline PIP2 levels are insuffi-
cient for requisite IP3 production in the spine, even with apparent
anomalous lateral diffusion of PIP2 from the neighboring den-
drite (Brown and Loew, 2012). On average, the Purkinje neuron
has approximately 14 spines per micron of dendrite (Harris and
Stevens, 1988). Each spine is attached to the dendrite branch-
let by a neck with diverse morphology (Harris and Stevens,
1989) (see Supplemental Material, S3 IP3R1 in dendritic forma-
tion and spine morphology). Model 6 results showed that spine
necks of varying radii and lengths also restricted diffusion of
produced IP3 out of the spine head (Brown et al., 2008). This
supported experimental results from Santamaria et al. with IP3
diffusing more slowly in spiny dendrites than in aspiny den-
drites (Santamaria et al., 2006). This suggested that spines might
compartmentalize IP3 via spine necks. Simulation results from
Model 2 suggested local PIP2 sequestration as a likely source of
sufficient PIP2, to fine-tune an experimentally observed (Wang
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FIGURE 1 | Calcium signaling in cerebellar Purkinje neuron spiny
dendrites with various molecules involved in spinocerebellar ataxias.
When a parallel fiber (PF) stimulates a distal dendrite of the Purkinje
neuron, the neurotransmitter glutamate is released and binds its receptor,
metabotropic glutamate receptor (mGluR; from the group C family of G
protein-coupled receptors, GPCR), on the plasma membrane of the
Purkinje dendrite (Finch and Augustine, 1998; Takechi et al., 1998). This
leads to the activation of phospholipase C (PLC), a hydrolyzing enzyme
that cleaves PIP2 in the plasma membrane to produce diacylglycerol
(DAG) and IP3 (Cohen, 2003). DAG stays in the membrane, where it can
activate cytosolic molecules close to the membrane, such as PKC
(Nishizuka, 1984). IP3 diffuses away from the reaction site (the plasma
membrane) to its receptor on the endoplasmic reticulum (ER) (Berridge
et al., 2000). IP3 is also free to diffuse out of the spine head, through the
spine neck, into the adjacent dendrite, and along the length of dendrite
nearby, part of the dendritic reservoir. At the ER, IP3 binds its receptor,
IP3R; the channel opens, releasing calcium from the internal store into
the cytosol. This rise in calcium can activate calcium-dependent proteins,
including calmodulin, various kinases (including PKC), and other enzymes.
The climbing fiber (CF) stimulus depolarizes the entire neuron membrane,
opening the voltage-gated calcium channels (Ito et al., 1982). The calcium
that flows into the Purkinje neuron spine can also bind IP3R1, along with
IP3 from parallel fiber activation of the spine, leading to supralinear
calcium release. SCA, spinocerebellar ataxia; EA, episodic ataxia; QG,
quadrupedal gait ataxia; K Ch, potassium channels including Kv1.1
(mutated in Episodic Ataxia type 1; Imbrici et al., 2003), Kv3.3 (mutated in
SCA13; Waters et al., 2006), Kv4.3 (mutated in SCA1; Duarri et al., 2012
and SCA22 Lee et al., 2012), BK and SK, which are respectively, the large
(big) conductance calcium-activated voltage-gated potassium channel
which is the potassium channel involved in Purkinje membrane
repolarization, and the small conductance calcium-activated
voltage-independent potassium channel; DAG, diacylglycerol, which is a
product of PLC hydrolysis that along with calcium co-activates PKC; PIP2,
Phosphatidylinositol 4,5-bisphosphate, a plasma membrane phospholipid of
the inner leaflet that gives rise to DAG and IP3 when hydrolyzed; PLC,
phospholipase C, an enzyme that hydrolyzes PIP2 when activated by G-βγ
from mGluR; mGluR or Grm1, metabotropic glutamate receptor type 1
(Guergueltcheva et al., 2012); T, other glutamate transporters and
receptors including Grid2, Excitatory amino-acid transporter type 1 (EAAT1;
mutated in Episodic Ataxia type 6, de Vries et al., 2009), Excitatory
amino-acid transporter type 4 (EAAT4; Spectrin β, an anchor for EAAT4
and Grm1 is mutated in SCA5, Ikeda et al., 2006), and AMPAR; B,
calcium-binding proteins or buffers including calbindin and parvalbumin
(Supplemental Material, S1 Calcium buffers in SCA and Supplemental
Figure S2); mAtaxin, mutant ataxin proteins including Ataxin-1 through
Ataxin-7; ICpeptide, peptides that resemble the tip of IP3R1 and thereby
competitively bind mAtaxin; SERCA, sarcoendoplasmic reticulum calcium
ATPase, a transporter for calcium entry from the cytosol to the smooth
endoplasmic reticulum (ER); CARP, Carbonic anhydrase-related protein
(particularly CARP VIII), an IP3R1 antagonist (Türkmen et al., 2009)
(Supplemental Material, S4 IP3R1 suppression by CARP); RYR, ryanodine
receptor, a transporter of calcium from the ER to the cytosol in dendrites
(but not present in spines) in response to binding of specific ligands such
as ryanodine; Dantrolene, a drug that inhibits RYR (Supplemental Material,
S2 Calcium-induced calcium release crosstalk); PMCA, Plasma membrane
calcium ATP-ase transports calcium out of the cell; Ca Ch, calcium
channels including store-operate channels (SOC) for store-operated calcium
entry and Cav2.1, which is the main P-type calcium channel in PCs with
nonsense/missense mutations causing episodic ataxia type 2, expansion
of CAG repeats causing SCA6, and mutations in CavB4 an accessory
subunit for Cav2.1 causing EA5 (Escayg et al., 2000); IP3R, inositol
trisphosphate receptor (mutated in SCA15/16 and altered sensitivity in
SCA1-3, antagonized in QG ataxia), intracellular calcium release channel on
the endoplasmic reticulum gated by IP3; PKC, protein kinase C (mutated
in SCA14) expressed in Purkinje neurons helps control expression of
surface molecules including AMPAR. Adapted from Hernjak et al. (2005).
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et al., 2000; Sarkisov and Wang, 2008) time window between PF
and climbing fiber (CF; from the inferior olive) activation of the
Purkinje neuron spine. Stimulation from a single CF innervating
the Purkinje neuron cell body and proximal dendrites leads to cal-
cium influx across the plasma membrane, through voltage-gated
calcium channels (Ito et al., 1982) (Figure 1). Calcium binding
of IP3R1 increases open probability of the receptor (Fiala et al.,
1996). IP3R1 serves as the gate-keeper for IP3-induced calcium
release. Thus, coincidence detection at IP3R1 leads to more cal-
cium release than with activation of IP3R1 by IP3 or calcium
alone (Wang et al., 2000; Hernjak et al., 2005; Ogasawara et al.,
2008; Sarkisov and Wang, 2008; Brown et al., 2011).
“COMPENSATORY PATHOLOGY” IN A MOUSE MODEL OF HUMAN SCA1
Mutant Ataxin-1, Ataxin-2, and Ataxin-3 have multiple polyglu-
tamine (CAG, polyQ) repeats (Orr et al., 1993; Kawaguchi et al.,
1994; Pulst et al., 1996). Corresponding mouse models exhibit
complex behavior with reduced IP3R1 abundance (Lin et al.,
2000; Serra et al., 2004; Chou et al., 2008; Hansen et al., 2013)
juxtaposed with IP3R1 supersensitivity (Inoue et al., 2001; Serra
et al., 2004; Chen et al., 2008; Chou et al., 2008; Brown and
Loew, 2012). IP3R1 supersensitivity has been directly shown in
SCA2 and SCA3 (Chen et al., 2008; Liu et al., 2009), and specu-
lated in SCA1 (Liu et al., 2009; Kasumu and Bezprozvanny, 2012)
(Table 1). All three ataxic mouse models associate with supranor-
mal calcium release (Inoue et al., 2001; Chen et al., 2008; Liu et al.,
2009). Models 11 and 12 in the SCA modeling suite support the
plausibility of IP3R1 supersensitivity as a necessary component to
the Purkinje neuron dysfunction observed in SCA1 (Brown and
Loew, 2012).
One of many common denominators for downregulation
of calcium homeostasis and glutamatergic signaling proteins in
polyQ disorders (e.g., Orr et al., 1993; Kawaguchi et al., 1994;
Koide et al., 1994, 1999; Trottier et al., 1994; Pulst et al., 1996;
David et al., 1997; Nakamura et al., 2001) is transcription fac-
tor retinoid acid receptor-related orphan receptor alpha (RORα)
(Serra et al., 2006; Gehrking et al., 2011; Euler et al., 2012). Model
12 results suggest that downregulation of IP3R1, sarcoendoplas-
mic reticulum calcium ATPase (SERCA), homer, and various
other glutamatergic signaling proteins (Serra et al., 2004; Chou
et al., 2008) in SCA1, SCA2, and SCA3 may compensate for
IP3R1 supersensitivity (Brown and Loew, 2012). IP3R1 expres-
sion and sensitivity therefore cannot be considered independently
in these polyQ ataxias, but interdependently. Huntington’s disease
and dentatorubral-pallidoluysian atrophy (DLPRA) are related
polyQ disorders with increased IP3R1 sensitivity and reduced
IP3R1 abundance (Liu et al., 2009; Datta et al., 2011; Euler
et al., 2012; Suzuki et al., 2012). Although the phenotype in these
disorders is very different, Model 12 predicts that downregula-
tion of IP3R1 should compensate for supersensitivity. Conversely,
Model 12 suggests that downregulation of calcium buffers such
as calbindin and parvalbumin worsen pathology with potential
feedback and feedforward loops or network motifs (Brown and
Loew, 2012) (Supplemental Material, S1 Calcium buffers in SCA
and Supplemental Figure S2). This is supported by experimen-
tal observations (Vig et al., 1998, 2001). Upregulation of any
endogenous inhibitors of IP3R1 should also assist with homeosta-
sis (Supplemental Material, S4 IP3R1 suppression by CARP).
BK CHANNEL IN IP3R1-ASSOCIATED ATAXIA
BIOCHEMICOELECTROPHYSIOLOGICAL MODEL
IP3R1 interacts closely with the large conductance calcium-
activated voltage-gated potassium (BK) channel in glioma cells
(Weaver et al., 2007). BK channels appear in lipid rafts in the
plasma membrane apposed to the smooth ER (sER). IP3R1 also
functionally activates the BK channel in arterial smooth muscle
cells (Zhao et al., 2010). It is thought that in other cell types,
including neurons, BK channels may form physical complexes
with various plasma membrane calcium channels, resulting in a
proximity of only a few nanometers from the calcium channel
pores (Dai et al., 2009).
In Purkinje neurons, BK channels contribute to repolarization
of membrane potential transients in dendrites (Miyasho et al.,
2001) and afterhyperpolarization of action potentials at the soma
(Sausbier et al., 2004). BK channels are involved in several atax-
ias that converge on IP3R1-dependent signaling. BK knockout
mice are ataxic and show markedly decreased spontaneous firing
(tonic and bursting) of Purkinje neurons, with longer interspike
intervals due to lack of BK contribution to afterhyperpolarization
of the sodium (action potential) spikes which would normally
help to reset the sodium channels in wild type mice (Sausbier
et al., 2004; Brown and Loew, 2012). BK channels are activated
by the P/Q-type calcium channels (Walter et al., 2006), which are
mutated in episodic ataxia 2 (EA2) (Guida et al., 2001; Mantuano
et al., 2004; Tonelli et al., 2006; Walter et al., 2006) and spinocere-
bellar ataxia 6 (SCA6) (Ishikawa et al., 1997; Bürk et al., 2014).
In the SCA modeling suite (Models 8–9, 13–15), BK channels
plays a key role in mediating the effects of IP3R1-mediated cal-
cium release on electrophysiological signals (Brown and Loew,
2012). Combining electrophysiology with detailed biochemistry
leads to emergent properties (altered firing of the Purkinje neu-
ron in Models 13–15) that are not possible to simulate in purely
electrophysiological or biochemical models (Brown and Loew,
2012).
EXPANDING THE SCA MODELING SUITE
BIOCHEMICAL-ELECTROPHYSIOLOGICAL MODELING
There are other calcium channels that functionally couple with
IP3R1. The small conductance calcium-activated potassium (SK)
channels are not voltage-gated, but contribute to precision tim-
ing (Womack and Khodakhah, 2003; Womack et al., 2004;
Walter et al., 2006; Alviña and Khodakhah, 2010a,b). Targeted
overactivation of SK channels in SCA2 mice restores regular
pacemaking activity (Kasumu et al., 2012). Isolated underacti-
vation of SK channels without a counteracting mutation also
yields ataxic mice (Alviña and Khodakhah, 2010a). Addition
of this channel to the SCA models (Models 8–9, 13–15) will
help mediate the influence of biochemical calcium release on
electrophysiology.
GLUTAMATE RECEPTOR MODULATION BY PKC
With insufficient IP3R1, reduced calcium release should result
in decreased activation of conventional PKC isoforms. Normally,
cytosolic calcium and DAG together activate PKC (Nishizuka,
1984) (Figure 1). PKC phosphorylates α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptor (AMPAR), another
glutamate receptor, and other molecules that are recruited
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Table 1 | Neurological disorders in humans and mice involving IP3R1, calbindin (CB), parvalbumin (PV), and other calcium signaling proteins.
Disorder Mutant protein IP3R1-associated PV/CB References
Expression Sensitivity Direct binding Expression
SMOOTH ENDOPLASMIC RETICULUM CLUSTER
SCA1 Ataxin-1 Decreased M E Decreased Orr et al., 1993; Burright et al., 1995; Lin
et al., 2000; Inoue et al., 2001; Liu et al.,
2009
SCA2 Ataxin-2 Decreased Increased E Decreased Pulst et al., 1996; Liu et al., 2009; Hansen
et al., 2013
SCA3 Ataxin-3 Decreased Increased E M Dürr et al., 1996; Paulson et al., 1997;













David et al., 1997; Friedrich et al., 2012
Moseley et al., 2006; Krysa et al., 2012
SCA17 Ataxin-17 M M M M Nakamura et al., 2001
HD Huntingtin Decreased Increased E M Datta et al., 2011; Euler et al., 2012
DLPRA DLPRA Decreased M E Decreased Liu et al., 2009; Suzuki et al., 2012
SCA15 IP3R1 Decreased U U U van de Leemput et al., 2007; Hara et al.,
2008; Di Gregorio et al., 2010
SCA16 IP3R1 Decreased U U U Iwaki et al., 2008
QG CARP VIII U* M E U* Hirota et al., 2003; Yan et al., 2007;
Türkmen et al., 2009
PLASMA MEMBRANE CLUSTER
A-HL PMCA Decreased U U U Kurnellas et al., 2007
ARCCA mGluR U U U U Guergueltcheva et al., 2012
EA2/leaner Cav2.1 U U U Decreased Guida et al., 2001; Murchison et al., 2002;
Mantuano et al., 2004; Tonelli et al., 2006
SCA6 Cav2.1 U U U U Ishikawa et al., 1997
SCA14 PKC-γ U U U U Alonso et al., 2005; Shuvaev et al., 2011;
van Gaalen et al., 2013; Ji et al., 2014
SCA5 Spectrin β U U U U Ikeda et al., 2006
EA6 EAAT1 U U U U de Vries et al., 2009

























Imbrici et al., 2006
Waters et al., 2006
Duarri et al., 2012
Lee et al., 2012
SCA, spinocerebellar ataxia; HD, Huntington’s disease; DLPRA, dentatorubral-pallidoluysian atrophy; leaner, mouse model corresponding to EA2; EA, episodic ataxia;
QG, quadrupedal gait ataxia; ARCCA, autosomal-recessive congenital cerebellar ataxia. M, predicted by model; E, experimentally observed; U, Untested. U*, tested
and unchanged in mouse model very early on at age 14 days, which may be too early to show changes, based on reduced inositol 1,4,5-trisphosphate receptor
1 (IP3R1) expression at age 26 days in the SCA2 mice (Hansen et al., 2013) (Supplemental Material, S4 IP3R1 suppression by CARP). ITPR1, intracellular calcium
release channel on the endoplasmic reticulum gated by IP3; PKC-γ , kinase expressed in Purkinje neurons; CARP VIII, Carbonic anhydrase-related protein 8 (CA8), an
IP3R1 antagonist (Türkmen et al., 2009); EAAT1, Excitatory amino-acid transporter type 1 (a glutamate transporter); Spectrin β, an excitatory amino-acid transporter
type 1 (EAAT4; glutamate transporter) and GluRδ2 (Grid2, glutamate receptor) anchor; DAG, diacylglycerol a product of PLC hydrolysis that activates PKC along with
calcium; PIP2, Phosphatidylinositol 4,5-bisphosphate, a plasma membrane phospholipid of the inner leaflet that gives rise to DAG and IP3 when hydrolyzed; PLC,
phospholipase C, an enzyme that hydrolyzes PIP2 when activated by G-betagamma from mGluR; mGluR or Grm1, metabotropic glutamate receptor type 1; PMCA,
Plasma membrane calcium ATP-ase transports calcium out of the cell; Cav2.1, main P-type calcium channel in PCs, with nonsense/missense mutations causing
episodic ataxia type 2 and expansion of CAG repeats causing SCA6; CavB4, accessory subunit that regulates P-type channels encoded by Cav2.1; Kv1.1, Kv3.3, and
Kv4.3 are potassium channels that contribute to repolarization of dendritic calcium spikes in Purkinje neurons; A-HL, ataxia and hearing loss in mice, hearing loss in
humans. Adapted from Schorge et al. (2010).
to the plasma membrane and induce AMPAR internalization
(Chung et al., 2000, 2003). This depresses Purkinje neuron
dendritic spine response to PF stimuli (Figure 1). Human
SCA14 involve PKC mutations (Alonso et al., 2005; Shuvaev
et al., 2011; van Gaalen et al., 2013; Ji et al., 2014) (Figure 1)
(Table 1), which can lead to aberrant AMPAR modulation.
Model 16 (“Brown et al., 2012—AMPAR.PKC.PP2A.NO”
at www.vcell.org) simulates PKC-AMPAR signaling and
can be incorporated into other SCA models (Models 10–
15) to investigate SCA14. This PKC-AMPAR sub-model
is adapted from simulations by Ogasawara et al. (2007,
2008).
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PKC IMPACT ON BK CHANNEL ACTIVITY
Phosphorylation by PKC also inhibits neuronal BK channel activ-
ity (Shipston and Armstrong, 1996). Decreased PKC levels could
therefore attenuate BK inhibition. This would balance suppres-
sion of BK channel activation by lower calcium transients in
IP3R1-deficient Purkinje spines. Merging Models 13 and14 with
Model 16 could illustrate contributions of BK regulation by
PKC phosphorylation to SCAs. Protein kinase A (PKA) (Hall
and Armstrong, 2000; Widmer et al., 2003) and PIP2 activation
of BK and other potassium channels (Hilgemann et al., 2001;
Falkenburger et al., 2010; Zhang et al., 2010) could also be added
to these models.
POTENTIAL CONFIRMATORY STUDIES TO TEST SCA
MODELING SUITE PREDICTIONS
SCA MOUSE MODELS
In addition to SCA1, SCA2, and SCA3 mice (Colomer Gould,
2012; Hansen et al., 2013; Hearst et al., 2014; Switonski
et al., 2014), there are other mouse models available for test-
ing SCA modeling suite predictions. The IP3R1+/− mice can
most be likened to IP3R1 haploinsufficiency in humans with
SCA15/SCA16 (Ogura et al., 2001; van de Leemput et al., 2007;
Hara et al., 2008; Iwaki et al., 2008; Di Gregorio et al., 2010;
Novak et al., 2010b; Castrioto et al., 2011; Marelli et al., 2011;
Obayashi et al., 2012) (Model 10). The ITPR1opt/opt mice also
have reduced IP3R1. However, IP3R1 is likely misregulated in
these mice, as evidenced by IP3R1-mediated calcium transients
that paradoxically show less attenuation to repeated stimulation
than wild type mice (Street et al., 1997). If IP3R1 sensitivity is
increased in ITPR1opt/opt mice, then these mice could serve as
an additional candidate model for polyQ ataxias or other atax-
ias with decreased expression of supersensitive IP3R1 (see Model
11). Similarly, the reported SCA15 mouse model ITPR118/18
shows reduced levels of IP3R1, but the 18 bp mutation is in
the regulatory region of IP3R1 (van de Leemput et al., 2007).
Calcium release and membrane electrophysiology need to be
probed in these mice to ascertain whether they match the antici-
pated physiology of SCA15. Human SCA29 has missense muta-
tions in the regulatory domain of IP3R1 (Huang et al., 2012)
and would also need such studies in any corresponding mouse
model.
EXPERIMENTALLY AVAILABLE ICpeptides
A number of synthetic experimental peptides resembling sections
of the C-terminal of IP3R1 are available for competitive binding
in SCA mouse models. The IC4 peptide (also reported as IC1,
Q2714-A2749; Tang et al., 2003; Tu et al., 2004) is available for
competitive inhibition of PP1α in ataxias with reduced levels of
IP3R1 (simulated inModel 10). IP3R1 dephosphorylation by pro-
tein phosphatase alpha (PP1α) decreases IP3R1 sensitivity to IP3
(Tang et al., 2003). IC4 (ICpeptide, Figure 1) resembles the tip of
the C-terminal of IP3R1 that encodes the PP1α-binding domain.
All these peptides can be used to validate and confirm predictions
from the SCA modeling suite. The IC-G2736X and IC-10 pep-
tides (Tang et al., 2009) are available for competitive inhibition of
mutant Ataxin in ataxias with supersensitive IP3R1 (IC-G2736X
simulated in Model 11). Peptide-based therapeutic approaches
(Lucchese and Kanduc, 2014) could use viral vectors, as explored
for Huntington’s disease (HD) (Tang et al., 2009).
CLINICAL TRANSLATION
The SCA modeling suite is poised for continued use in transla-
tional studies (Brown et al., 2015). Cerebellar IP3R1 levels (Ogura
et al., 2001; van de Leemput et al., 2007) in various SCA mouse
models could be experimentally correlated with levels of periph-
eral lymphocyte IP3R1 from the samemice. The two sets of values
could be plotted against each other. Levels of peripheral lym-
phocyte IP3R1 from ataxic individuals (van de Leemput et al.,
2007) could then potentially be compared with corresponding
levels in mice to estimate cerebellar levels in humans. In one study
of SCA15, Western blot showed variably reduced IP3R1 levels in
peripheral lymphocytes from three affected members of the same
family relative to an unaffected family member (van de Leemput
et al., 2007). Measuring peripheral blood lymphocyte levels of
IP3R1 would be relatively noninvasive for humans. Correlated
estimates of cerebellar IP3R1 would be useful to help guide
therapy, particularly in presymptomatic patients who have under-
gone genetic testing and counseling (Supplemental Material, S1.6
Presymptomatic staging to consider calbindin modulation).
FUNCTIONAL CONSIDERATION OF IP3R1 IN ATAXIA
IP3R-mediated calcium release occurs in various tissues (see deS-
ouza et al., 2007; Mondin et al., 2009; Cárdenas et al., 2010; Chen
et al., 2010; Ehrlich et al., 2010; Healy et al., 2010; Mandal et al.,
2010; Park et al., 2010) including peripheral lymphocytes, but
IP3R1 mutations in mice and humans (Matsumoto et al., 1996;
Street et al., 1997; Ogura et al., 2001; van de Leemput et al., 2007)
(van de Leemput et al., 2007; Hara et al., 2008; Iwaki et al., 2008;
Di Gregorio et al., 2010; Huang et al., 2012) lead to primarily
cerebellar defects. Nevertheless, the IP3R1−/− (Matsumoto et al.,
1996) and IP3R1opt/opt (Street et al., 1997) mice also present with
epileptic symptoms, and the conditional cerebellum/brainstem
IP3R1 knockout mice and waddles mice present with dystonia
(Jiao et al., 2005; Hisatsune et al., 2013) (Supplemental Material,
S5 IP3R1 in basal ganglia-independent dystonia).
Most tissues have similar concentrations of all three IP3R iso-
forms or favor high levels of IP3R2 or IP3R3 over IP3R1 (De
Smedt et al., 1997; Tu et al., 2005). Yet, 90% of IP3R in the cerebel-
lar Purkinje neuron is IP3R1 (De Smedt et al., 1997). Insufficient
levels of IP3R1 remarkably disrupt Purkinje neuron function, as
observed in ataxia (SCA15 van de Leemput et al., 2007; Hara et al.,
2008; Iwaki et al., 2008; Di Gregorio et al., 2010; Novak et al.,
2010a,b; Marelli et al., 2011).
Other tissues such as smooth muscle, which has 75% of IP3R
as IP3R1 (De Smedt et al., 1997), and peripheral lymphocytes, in
which themajor IP3R isoform is also type 1 (deSouza et al., 2007),
likely have compensatory mechanisms involving 25% of IP3R as
IP3R2 and IP3R3 to overcome IP3R1 deficits. In addition, there
are two regulatory domain phosphorylation site splice variants of
IP3R1 (Tu et al., 2002; Wagner et al., 2003). S(II) is favored in the
brain (Wagner et al., 2003). Other tissues, such as smooth mus-
cle and peripheral lymphocytes, may differentially phosphorylate
their IP3R1 at S(I) (Tang et al., 2003) in response to insufficient
levels of the receptor.
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Further, there is a high density of sER containing IP3R1 in
Purkinje spines (calculated average of ∼15% of spine volume
from Harris and Stevens, 1988), relative to hippocampal spines
(reported as<5% of spine volume fromHarris and Stevens, 1989)
(Supplemental Material, S6 IP3R1 in hippocampal spines), which
are important for synaptic plasticity involved in cognitive learn-
ing and memory. This suggests that IP3R1 on sER preferentially
serves particular functions in Purkinje spines that may manifest
differently in other cell types.
All of these reasons underlie the observation that in IP3R1
mutations, and in several human ataxias with biochemical and
electrophysiological signals that converge on IP3R1-dependent
signaling (Mikoshiba, 2007; Schorge et al., 2010), the primary
clinical manifestation is spinocerebellar ataxia.
SCA IN COMPUTATIONAL SYSTEMS NEUROBIOLOGY
Spatial quantitative models have given some insight into how
cerebellar Purkinje neuron intracellular processes work together
as an efficient system. A computational foundation for study-
ing a wide array of spinocerebellar ataxias that involve muta-
tions in various calcium and potassium channels, kinases, and
other molecules, including IP3R1 was developed (Supplemental
Material, Supplemental Figure S1). The result is a practical appli-
cation of Computational Systems Neurobiology (Brown et al.,
2012). Using these models to study various ataxias will help us
to explain a wide array of experimental observations, elucidate
cellular causes of these ataxias in mice and humans, and further
understand the relationship between cytosolic calcium and mem-
brane electrophysiology. The SCA modeling suite can help char-
acterize the cellular pathophysiology of IP3R1-associated ataxia.
That will help us to understand the biochemical and electrophys-
iological coupling in excitable membranes, since IP3R1 is highly
expressed in the brain, and enriched in the cerebellum (Furuichi
et al., 1989; De Smedt et al., 1997; Mikoshiba, 2007).
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